The beginning of the end of the beginning in cancer genomics

New England Journal of Medicine

Volumn 368, Issue 22, 2013, Pages 2138-2140

  Steensma, David P ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DAUNORUBICIN; DNA METHYLTRANSFERASE; IMATINIB; PROTEIN TYROSINE KINASE INHIBITOR;

ACUTE GRANULOCYTIC LEUKEMIA; CANCER GENETICS; CHRONIC MYELOID LEUKEMIA; EDITORIAL; GENE SEQUENCE; GENETIC ANALYSIS; GENOME; HUMAN; METABOLOMICS; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; SOMATIC MUTATION;

EID: 84878366253     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMe1303816     Document Type: Editorial

References (12)

1. Collins FS, Morgan M, Patrinos A. The Human Genome Project: lessons from large-scale biology. Science 2003;300:286-90. (Pubitemid 36433711)
2. Ley TJ, Mardis ER, Ding L, et al. DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome. Nature 2008;456:66-72.
3. Weinberg R. Point: hypotheses first. Nature 2010;464:678.
4. Kaiser J. A skeptic questions cancer genome projects. Science Insider. April 23, 2010 (http://news.sciencemag.org/scienceinsider/2010/04/a-skeptic- questions-cancer-genom.html).
5. The Cancer Genome Atlas Research Network. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med 2013;368:2059-74.
6. Druker BJ, Talpaz M, Resta DJ, et al. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. N Engl J Med 2001;344:1031-7. (Pubitemid 32267972)
7. Gorre ME, Mohammed M, Ellwood K, et al. Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification. Science 2001;293:876-80. (Pubitemid 32743979)
8. Sierra JR, Cepero V, Giordano S. Molecular mechanisms of acquired resistance to tyrosine kinase targeted therapy. Mol Cancer 2010;9:75.
9. Mardis ER, Ding L, Dooling DJ, et al. Recurring mutations found by sequencing an acute myeloid leukemia genome. N Engl J Med 2009;361:1058-66.
10. Ley TJ, Ding L, Walter MJ, et al. DNMT3A mutations in acute myeloid leukemia. N Engl J Med 2010;363:2424-33.
11. Walter MJ, Shen D, Ding L, et al. Clonal architecture of secondary acute myeloid leukemia. N Engl J Med 2012;366:1090-8.
12. Patel JP, Gonen M, Figueroa ME, et al. Prognostic relevance of integrated genetic profiling in acute myeloid leukemia. N Engl J Med 2012;366:1079-89.